Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Folsom

Showing results (61-70 of 64) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 64 results.
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Frontiers in Public Health|December 19, 2013
A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panelRichard E Frye, Daniel Rossignol, Manuel F Casanova, et al.
Molecular Therapy. Oncology|January 15, 2026
Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcomaGabrielle M Robbins, Jae-Woong Chang, Joshua B Krueger, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Pageof 7

Showing results (61-70 of 64) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 64 results.
Cytotherapy|July 17, 2025
Clinical manufacture of CRISPR/Cas9-based cytokine-induced SH2 protein knock-out tumor-infiltrating lymphocytes for gastrointestinal cancersMatthew J Johnson, Darin Sumstad, Timothy D Folsom, et al.
Frontiers in Public Health|December 19, 2013
A review of traditional and novel treatments for seizures in autism spectrum disorder: findings from a systematic review and expert panelRichard E Frye, Daniel Rossignol, Manuel F Casanova, et al.
Molecular Therapy. Oncology|January 15, 2026
Non-viral TcBuster transposon engineering of CD70-CAR natural killer cells for the treatment of osteosarcomaGabrielle M Robbins, Jae-Woong Chang, Joshua B Krueger, et al.
The Lancet. Oncology|May 2, 2025
Targeting the intracellular immune checkpoint CISH with CRISPR-Cas9-edited T cells in patients with metastatic colorectal cancer: a first-in-human, single-centre, phase 1 trialEmil Lou, Modassir S Choudhry, Timothy K Starr, et al.
Pageof 7